The organ is characterized by intense blood flow, abundantly supplied with fresh blood, which flushes micrometastases from the lymph nodes and pancreas, making it difficult to diagnose early. The destructive effect lasts for years imperceptibly for a person, revealing its presence too late for a quality healing. The effectiveness of chemotherapy gland is about 20%, radiotherapy is even less, inoperability is present in half of all cases. Severe pain often means that the oncology of the organ progresses, the tumor has gone beyond it by distant metastases.
In the early stages before the diagnosis is made, the risk of pancreatic cancer on a regular basis is reduced, phytotherapy. Herbs contain plant-friendly poisons that harm the human being, which destroy malignant and benign onco tumors. These are tinctures of a milestone and dope, aconite and comfrey, alcoholic elixir of Godin. Early diagnosis of the pancreas is widely used by oncomarkers.
The method is low-cost, does not require expensive equipment, it is based on the counting of proteins( or their compounds), characteristic of oncology of a particular organ. For each of them protein compounds are individual, including for the pancreas, therefore, they are called markers. By results of researches it is much easier to understand necessity of the further hardware diagnosing.
Pancreatic markers of the pancreas
Proteins and derivatives from them can accurately characterize the presence of infected cells in the body. These substances are called markers that easily identify many onco components and determine:
- the quality of the operation to remove
- treatment control( efficacy)
- the presence of recurrences of the cancer of the
- tumor source before the beginning of the full study
- of the high-risk group
The medicine uses two dozen oncomarkers, specificallyfor pancreatic cancer are characteristic:
- CEA - nonspecific( present in all smokers), norm 5 ED
- CA 19-9 - on the presence of oncology in the organ, or on the process of treatment of the witnessIncreases from 37 U / l( cancer cells begin to disintegrate, excrete from the body)
PAP markers, SMA are considered additional, for all analyzes of this type, venous blood is taken. An increase in the main marker CA 19-9 occurs in 80% of patients. Five percent of the population lacks the enzyme that synthesizes this cancer marker, so they are being examined for CA 50.
An analysis of pancreatic cancer markers allows detection of oncology at early stages, while other ways of detecting affected tissues may be ineffective. It is timely analysis and diagnosis of the disease at an early stage allows you to start a successful treatment.
An analysis for tumor markers is assigned when there are suspicions of oncology, it is necessary to determine the stage of the disease and when it is necessary to determine the effectiveness of the prescribed treatment. Such a blood test helps to detect a relapse in time and allows you to observe the general state of the human body after applying radical methods.
Norm of pancreatic cancer markers
There are more than 200 cancer markers in total, but only a few of them have a real value in blood analysis. Oncomarker of the pancreas is CA-19-9.Its normal values range from 30 to 40 IU / ml. If there is a value of more than 40 IU / ml, one can speak of a tumor in the patient. It should be borne in mind that this tumor markers are present in small quantities in pancreatic cells, moreover, it is not characterized by high specificity, therefore it is not suitable for screening. The analysis on CA-19-9 is desirable to be conducted several times and in the same center, in order to obtain the most truthful and reliable results. To clarify the diagnosis, it is recommended that simultaneously with a blood test for pancreatic cancer cancer markers, gamma glutamate transferase and alkaline phosphatase should be investigated. If the concentration exceeds the norm value of 1000 conventional units, this indicates the presence of the disease, and only 5% of patients have a tumor that is operable, with less than 1,000 - in 50%.If an operation is performed, but the concentration of markers is still increasing, it indicates a relapse.
Pancreatic Oncological Diseases
Oncology of the pancreas is dangerous, first of all, because before the development of the fourth stage the disease is practically asymptomatic and it is difficult to detect it, but, at the same time, pancreatic cancer is very aggressive. Adenocarcinoma is the most common form of pancreatic cancer. Most often develops in men.
It is worth noting the fact that only 20% of cases of pancreatic cancer are detected when the tumor is limited only to this organ. If you have the first symptoms, undefined pain, you should immediately go to a medical institution for a survey. The earlier oncology is detected, the easier and more effective the treatment will be.
Pancreatic Oncology - Symptoms and Treatment of
Even with all the complexity of the oncology of the pancreas, symptoms of early detection of the disease exist. Depending on the location of the tumor, they may be somewhat different.
With a pancreatic head cancer, a person may experience abdominal pain, persistent nausea, weight decreases for uncertain reasons, jaundice may develop. With oncology of the body and tail, there is a sharp decrease in weight and pain in the abdomen.
The body of each person is individual, so in oncology, in some cases, there may be additional symptoms such as: dizziness, decreased appetite, constant nausea, itchy skin. If you have symptoms, you need to undergo a full medical examination. Oncology is diagnosed with the help of computed tomography and ultrasound. It is also necessary to donate blood for the detection of the oncomarker and to perform puncture.
Treatment of pancreatic oncology depends on the stage of the disease. In the first-second stage, when the tumor has small dimensions, pancreaticoduodenectomy or distal pancreatectomy is prescribed. After successful surgery, several courses of chemotherapy are prescribed. In the second and third stages( if the tumor is already outside the body) the disease is almost unresectable. If there is no metastasis in the nerves and magistral vessels, gastro-pancreatoduodenal resection may be prescribed, followed by chemotherapy.
The fourth stage involves the presence of metastases, the main treatment will be chemotherapy with a variety of drugs.